Robertson J S, Price R R, Budinger T F, Fairbanks V F, Pollycove M
J Nucl Med. 1983 Apr;24(4):339-48.
Biological data obtained principally with Fe-59 citrate are used with physical data to calculate radiation absorbed doses for ionic or weak chelate forms of Fe-52, Fe-55, and Fe-59, administered by intravenous injection. Doses are calculated for normal subjects, primary hemochromatosis (also called idiopathic or hereditary hemochromatosis), pernicious anemia in relapse, iron-deficiency anemia, and polycythemia vera. The Fe-52 doses include the dose from the Mn-52m daughter generated after injection of Fe-52. Special attention has been given to the dose to the spleen, which has a relatively high concentration of RBCs and therefore of radioiron, and which varies significantly in size in both health and disease.
主要通过柠檬酸铁-59获得的生物学数据与物理数据一起,用于计算静脉注射的铁-52、铁-55和铁-59的离子或弱螯合物形式的辐射吸收剂量。计算了正常受试者、原发性血色素沉着症(也称为特发性或遗传性血色素沉着症)、复发的恶性贫血、缺铁性贫血和真性红细胞增多症的剂量。铁-52的剂量包括注射铁-52后产生的锰-52m子体的剂量。特别关注了脾脏的剂量,脾脏中红细胞浓度相对较高,因此放射性铁的浓度也相对较高,并且在健康和疾病状态下其大小都有显著变化。